BioSpace News Archive

Readout Health, a digital biomarker startup, announced today its partnership with Apollo Health, a health technology leader in neurodegenerative medicine. Apollo Health has created the first online community of specially trained healthcare practitioners and participants partnering to use a science-based protocol demonstrated to prevent and reverse cognitive decline.

Xenon Pharmaceuticals Inc., a clinical stage biopharmaceutical company, announced that Dr. Simon Pimstone, Xenon’s Chief Executive Officer, will participate in the following virtual investor conferences

Texas Children’s Hospital moves finance, HR, and supply chain processes to Oracle Cloud Applications to improve employee engagement, integrate and simplify processes, and increase adaptability

China Jo-Jo Drugstores, Inc., a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, announced its financial results for the second fiscal quarter ended September 30, 2020.

Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announces that Michael Poirier, President, Chief Executive Officer and Chairman, has issued a letter to Qualigen’s stockholders.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced the publication of positive results from a study of antiviral activity of FDA approved drugs in a peer-reviewed article in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).

ExeGi Pharma LLC, a company focused on developing live biotherapeutic (“LBP”) drugs and probiotics, announced today that its biologic drug candidate, EXE-346, has received an orphan drug designation from the U.S. Food and Drug Administration (FDA) for the prevention of disease relapse in pouchitis.

DURECT Corporation (Nasdaq: DRRX) today presented additional safety data and efficacy signals from its Phase 1b clinical trial of DUR-928 in nonalcoholic steatohepatitis (NASH) patients in a poster presentation at The AASLD Liver Meeting Digital Experience ™ (TLMdX) 2020.

EyeMD EMR Healthcare Systems Inc., a leading provider of Electronic Medical Records (EMR) software designed specifically for ophthalmologists, will debut EyeMD EMR 2.0, an all-in-one EMR, PM and PACS system at the American Academy of Ophthalmology® (AAO) Virtual Conference, taking place Nov. 13–15, 2020.

SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride ceramic for medical and non-medical applications, and Iwatani Corporation of America (ICA), a wholly-owned subsidiary of Iwatani Corporation, announced today that they have entered into a joint development agreement.